📊Financials 📈PE Ratio 🥧Shareholding 💰Dividend 📋Quarterly ⚖️Balance Sheet 💹P&L 🌊Cash Flow

TRABIHealthcare Service Provider

Transgene Biotek Ltd — Financial Ratios & Key Metrics

₹1.98

-2.15%

P/E RatioN/AxIndustry: 39.28x

ROE-6.56%Return on equity

ROCE-1.75%Return on capital

Debt/Equity1.79High debt

💎

Valuation & Profitability

P/E Ratio

N/Ax

Industry Average P/E

39.28x

Dividend Yield

0.00%

Market Cap

₹26.14 (Cr)

Sales Growth 5Y

N/A

Profit Growth 5Y

14.15%

EPS Growth 5Y

14.15%

OPM 5Y Avg

-411.11%

📉

Price Returns

1 Month

-8.73%

3 Months

-7.75%

6 Months

-13.75%

1 Year

-46.51%

52W Low

₹2

Current

₹2

52W High

₹5

4% of 52-week range — Near lows

🔬

Technical Indicators

Oversold

Selling pressure is heavy — potential reversal zone.

SMA 50

₹2

▼ Price below SMA 50 — Bearish

SMA 200

₹4

▼ Long-term downtrend

Volume Signal

213% of avg

Above average volume — strong conviction behind price move

Technical indicators are for educational purposes only. Not investment advice.

More on Transgene Biotek Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Healthcare Service Provider Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.